-
-
-
-
-
-
-
Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C.
-
-
-
-
-
-
-
Clearmind Medicine files Hong Kong patent for depression therapy combo
-
-
-
-
-
-
-
Clearmind Medicine regains compliance with NASDAQ stockholders' equity rule
-
-
-
-
-
-
-
Clearmind Medicine receives NASDAQ notice for equity deficiency
-
-
-
-
-
-
-
Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders
-
-
-
-
-
-
-
Clearmind Medicine (CMND) Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
-
-
-
-
-
-
-
Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China
-
1,157,743 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

